Published in Thyroid on August 01, 2002
Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immunol (2004) 1.61
Assessment of significance of features acquired from thyroid ultrasonograms in Hashimoto's disease. Biomed Eng Online (2012) 1.15
The prevalence of thyroid dysfunction in elderly cardiology patients with mild excessive iodine intake in the urban area of São Paulo. Clinics (Sao Paulo) (2009) 0.89
Heterogeneous echogenicity of the underlying thyroid parenchyma: how does this affect the analysis of a thyroid nodule? BMC Cancer (2013) 0.82
Influence of the measurement method of features in ultrasound images of the thyroid in the diagnosis of Hashimoto's disease. Biomed Eng Online (2012) 0.78
Vitamin D supplementation reduces thyroid peroxidase antibody levels in patients with autoimmune thyroid disease: An open-labeled randomized controlled trial. Indian J Endocrinol Metab (2016) 0.78
Correlation of normal thyroid ultrasonography with thyroid tests. Quant Imaging Med Surg (2015) 0.77
Can thyroid volume predict thyroid dysfunction in patients with systemic sclerosis? A prospective cross-sectional study from a tertiary care center in North West India. Clin Rheumatol (2016) 0.77
Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed - A Review for Primary Care. Clin Med Res (2016) 0.76
Importance of Delphian Lymph Node Evaluation in Autoimmune Thyroiditis: Fact or Fiction? Pol J Radiol (2016) 0.75
Focal Lymphocytic Thyroiditis Nodules Share the Features of Papillary Thyroid Cancer on Ultrasound. Yonsei Med J (2015) 0.75
Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes (2002) 3.01
Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes (2005) 2.55
Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med (2007) 2.17
Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans. Diabetologia (2015) 2.11
The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes (2007) 2.09
Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes (2004) 1.76
Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes (2006) 1.72
Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology (2009) 1.49
Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes (2002) 1.41
Vitamin D status and its relation to age and body mass index. Horm Res (2006) 1.35
Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab (2007) 1.29
Relationship between serum lipoprotein ratios and insulin resistance in obesity. Clin Chem (2004) 1.25
Direct noninvasive quantification of lactate and high energy phosphates simultaneously in exercising human skeletal muscle by localized magnetic resonance spectroscopy. Magn Reson Med (2007) 1.10
Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr (2011) 1.09
Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate. Eur J Nucl Med Mol Imaging (2004) 1.09
Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization. Clin Endocrinol (Oxf) (2003) 1.07
Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). Clin Endocrinol (Oxf) (2008) 1.05
The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care (2007) 1.05
Thyrotropin serum concentrations in patients with papillary thyroid microcancers. Thyroid (2010) 1.02
A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects. Am J Physiol Endocrinol Metab (2007) 0.96
Long term control of hypercortisolism with fluconazole: case report and in vitro studies. Eur J Endocrinol (2006) 0.94
Renal elimination of sclerostin increases with declining kidney function. J Clin Endocrinol Metab (2013) 0.93
Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab (2007) 0.93
Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. J Clin Endocrinol Metab (2007) 0.93
Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes. Diabetes (2011) 0.92
The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans. J Clin Endocrinol Metab (2004) 0.91
Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia. Diabetes (2002) 0.89
Volumetric intravascular ultrasound imaging to illustrate the extent of coronary plaque burden in type 2 diabetic patients. J Diabetes Complications (2007) 0.88
Different mechanisms of saturated versus polyunsaturated FFA-induced apoptosis in human endothelial cells. J Lipid Res (2008) 0.88
Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab (2007) 0.88
Liver X receptors regulate adrenal steroidogenesis and hypothalamic-pituitary-adrenal feedback. Mol Endocrinol (2006) 0.87
Lipid-induced insulin resistance is not mediated by impaired transcapillary transport of insulin and glucose in humans. Diabetes (2012) 0.87
Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function? Diabetes Care (2006) 0.86
Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesity. Diabetes (2008) 0.86
Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients. Diabetes Care (2008) 0.85
Production rates of cortisol in obesity. Obes Res (2004) 0.85
Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters. Obes Surg (2012) 0.84
Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function. J Clin Endocrinol Metab (2014) 0.84
The role of endocrine counterregulation for estimating insulin sensitivity from intravenous glucose tolerance tests. J Clin Endocrinol Metab (2006) 0.84
Quantitative liver 31P magnetic resonance spectroscopy at 3T on a clinical scanner. Magn Reson Med (2013) 0.83
Quantifying the improvement of surrogate indices of hepatic insulin resistance using complex measurement techniques. PLoS One (2012) 0.83
Reduction of non-esterified fatty acids improves insulin sensitivity and lowers oxidative stress, but fails to restore oxidative capacity in type 2 diabetes: a randomised clinical trial. Diabetologia (2013) 0.82
Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly. PLoS One (2008) 0.82
Adequately adapted insulin secretion and decreased hepatic insulin extraction cause elevated insulin concentrations in insulin resistant non-diabetic adrenal incidentaloma patients. PLoS One (2013) 0.82
Cardiometabolic phenotyping of patients with familial hypocalcuric hypercalcemia. J Clin Endocrinol Metab (2014) 0.80
Thiazolidinediones influence plasma steroids of male obese Zucker rats. Endocrinology (2002) 0.80
Vascular function in obese children with non-alcoholic fatty liver disease. Int J Pediatr Obes (2010) 0.80
No evidence of ectopic lipid accumulation in the pathophysiology of the acromegalic cardiomyopathy. J Clin Endocrinol Metab (2014) 0.80
Age-dependent development of metabolic derangement and effects of intervention with pioglitazone in Zucker diabetic fatty rats. J Pharmacol Exp Ther (2008) 0.80
The usefulness of thyrotropin-releasing hormone stimulation test in subfertile female patients. Gynecol Endocrinol (2008) 0.79
Reduction of plasma leptin concentrations by arginine but not lipid infusion in humans. Obes Res (2002) 0.79
Measurement of calcitonin by immunoassay analyzers. Clin Chem Lab Med (2007) 0.79
Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations. Clin Endocrinol (Oxf) (2009) 0.79
Recommendations for reporting C cell pathology of the thyroid. Wien Klin Wochenschr (2002) 0.78
Skeletal muscle phosphodiester content relates to body mass and glycemic control. PLoS One (2011) 0.78
Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin. Wien Klin Wochenschr (2002) 0.78
Modulation of amino acid metabolic signatures by supplemented isoenergetic diets differing in protein and cereal fiber content. J Clin Endocrinol Metab (2014) 0.78
Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism? Thyroid (2002) 0.78
Sex-specific difference in the interconversion of cortisol and cortisone in men and women. Obesity (Silver Spring) (2007) 0.78
Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance. J Clin Invest (2017) 0.78
A Case of simultaneous occurrence of Marine - Lenhart syndrome and a papillary thyroid microcarcinoma. BMC Endocr Disord (2013) 0.77
A simple micro-photometric method for urinary iodine determination. Clin Chem Lab Med (2011) 0.77
HORMONE SUBSTITUTION AFTER GASTRIC BYPASS SURGERY IN PATIENTS WITH HYPOPITUITARISM SECONDARY TO CRANIOPHARYNGIOMA. Endocr Pract (2016) 0.77
Multiple endocrine neoplasia 1--current recommendations for diagnosis and treatment. Wien Klin Wochenschr (2002) 0.76
Abnormal plasma peptide YY(3-36) levels in patients with liver cirrhosis. Nutrition (2011) 0.76
Long-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman. Endocr Pathol (2003) 0.76
Can dynamic gadolinium-enhanced magnetic resonance imaging with chemical shift studies predict the status of adrenal masses? World J Surg (2002) 0.75
[Lesions in subacute Quervain's thyroiditis are not hypervascularized]. Med Klin (Munich) (2008) 0.75
A newly identified RET proto-oncogene polymorphism is found in a high number of endocrine tumor patients. Hum Genet (2005) 0.75
Re: "Is it necessary to obtain serum levels of thyroid stimulating hormone and prolactin in asymptomatic women with infertility?". Conn Med (2004) 0.75
Lymphocytic Hypophysitis Presenting as a Pituitary Tumor in a 63-Year-Old Man. Endocr Pathol (1995) 0.75
Anti-ruthenium antibodies mimic macro-TSH in electrochemiluminescent immunoassay. Clin Chem Lab Med (2014) 0.75
Vascular endothelial growth factor in thyroid cyst fluids. Wien Klin Wochenschr (2007) 0.75
Low-dose calcium versus pentagastrin for stimulation of calcitonin in chronic hemodialysis patients: a pilot study. J Clin Endocrinol Metab (2014) 0.75
Multiple endocrine neoplasia type 1 (MEN1) in Austria. Wien Klin Wochenschr (2002) 0.75
Imaging of adrenocortical metastases with [11C]metomidate. Eur J Nucl Med Mol Imaging (2006) 0.75